Canlyniadau Chwilio - Sergio Ruiz‐Llorente

  • Dangos 1 - 7 canlyniadau o 7
Mireinio'r Canlyniadau
  1. 1
    CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation

    CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation gan Verónica García-Carpizo, Sergio Ruiz‐Llorente, Jacinto Sarmentero, Osvaldo Graña‐Castro, David G. Pisano, María J. Barrero

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level

    PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level gan Lucía Conde, Juan M. Vaquerizas, Javier Santoyo‐López, Fátima Al‐Shahrour, Sergio Ruiz‐Llorente, Mercedes Robledo, Joaquı́n Dopazo

    Cyhoeddwyd 2004
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Relief of Feedback Inhibition of <i>HER3</i> Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in <i>BRAF</i>-Mutant Thyroid Carcinomas

    Relief of Feedback Inhibition of <i>HER3</i> Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in <i>BRAF</i>-Mutant Thyroid Carcinomas gan Cristina Montero‐Conde, Sergio Ruiz‐Llorente, José Miguel Domínguez, Jeffrey A. Knauf, Agnès Viale, Eric J. Sherman, Mabel Ryder, Ronald Ghossein, Neal Rosen, James A. Fagin

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation

    NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation gan Verónica García-Carpizo, Jacinto Sarmentero, Bomie Han, Osvaldo Graña‐Castro, Sergio Ruiz‐Llorente, David G. Pisano, Manuel Serrano, Harold B. Brooks, Robert M. Campbell, María J. Barrero

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer

    Proteomic profiles of peritoneal fluid-derived small extracellular vesicles correlate with patient outcome in ovarian cancer gan Miguel Quiralte, Arántzazu Barquín, Mónica Yagüe-Fernández, Paloma Navarro, Tatiana P. Grazioso, Elena Sevillano-Fernández, Juan F. Rodríguez-Moreno, Alejandra Balarezo-Saldivar, Héctor Peinado, Elena Izquierdo, Carlos Millán, Irene López-Carrasco, Mario Prieto, Rodrigo Madurga, Ismael Fernández‐Miranda, Sergio Ruiz‐Llorente, Jesús García-Donás

    Cyhoeddwyd 2024
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors

    The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors gan Iñigo Landa, Sergio Ruiz‐Llorente, Cristina Montero‐Conde, Lucía Inglada‐Pérez, Francesca Schiavi, Susanna Leskelä, Guillermo Pita, Roger L. Milne, Javier Maravall, Ignacio Ramos, Victor Andía, Paloma Rodríguez-Poyo, Antonino Jara-Albarrán, Amparo Meoro, Cristina Del Peso, Luis Arribas, Pedro Iglesias, Javier Caballero‐Villarraso, Joaquín Serrano, Antonio Picò, Francisco Pomares, Gabriel Giménez, Pedro López-Mondéjar, Roberto Castello, Isabella Merante Boschin, Maria-Rosa Pelizzo, Dı́dac Mauricio, Giuseppe Opocher, Cristina Rodríguez‐Antona, Anna González‐Neira, Xavier Matías‐Guiu, Pilar Santisteban, Mercedes Robledo

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

    MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma gan Eun Young Kang, Joshua Millstein, Gordana Popović, Nicola S. Meagher, Adelyn Bolithon, Aline Talhouk, Derek S. Chiu, Michael S. Anglesio, Betty Leung, Katrina Tang, Neil Lambie, Marina Pavanello, Annalyn Da-Anoy, Diether Lambrechts, Liselore Loverix, Siel Olbrecht, Christiani Bisinotto, Jesús García-Donás, Sergio Ruiz‐Llorente, Mónica Yagüe-Fernández, Robert P. Edwards, Esther Elishaev, Alexander Olawaiye, Sarah E. Taylor, Beyhan Ataseven, Andreas du Bois, Philipp Harter, Jenny Lester, Claus Høgdall, Sebastian M. Armasu, Yajue Huang, Robert A. Vierkant, Chen Wang, Stacey J. Winham, Sabine Heublein, F. Kommoss, Daniel W. Cramer, Naoko Sasamoto, Lilian van‐Wagensveld, Maria Lycke, Constantina Mateoiu, Janine M. Joseph, Malcolm C. Pike, Kunle Odunsi, Chiu-Chen Tseng, Celeste Leigh Pearce, Sanela Bilic, Thomas P. Conrads, Arndt Hartmann, Alexander Hein, Michael E. Jones, Yee Leung, Matthias W. Beckmann, Matthias Ruebner, Minouk J. Schoemaker, Kathryn L. Terry, Mona El‐Bahrawy, Penny Coulson, John Lewis Etter, Katherine LaVigne-Mager, Juergen Andress, Marcel Grube, Anna Fischer, Nina Neudeck, Greg Robertson, Rhonda Farrell, Ellen Barlow, Carmel M. Quinn, Anusha Hettiaratchi, Yovanni Casablanca, Ramona Erber, Colin J.R. Stewart, Adeline Tan, Yu Yu, Jessica Boros, Alison H. Brand, Paul R. Harnett, Catherine J. Kennedy, Nikilyn Nevins, Terry K. Morgan, Peter A. Fasching, Ignace Vergote, Anthony J. Swerdlow, Francisco José Cândido dos Reis, G. Larry Maxwell, Susan L. Neuhausen, Arántzazu Barquín, Francesmary Modugno, Kirsten B. Moysich, Philip Crowe, Akira Hirasawa, Florian Heitz, Beth Y. Karlan, Ellen L. Goode, Hans‐Peter Sinn, Hugo M. Horlings, Estrid Høgdall, Karin Sundfeldt, Stefan Kommoss, Annette Staebler

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: